120
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Geniposidic acid protects lipopolysaccharide-induced acute lung injury via the TLR4/MyD88 signaling pathway in vitro and in vivo

&
Pages 984-992 | Received 01 Jan 2022, Accepted 26 Jun 2022, Published online: 15 Jul 2022

References

  • Hayes M, Curley G, Ansari B, et al. Clinical review: stem cell therapies for acute lung injury/acute respiratory distress syndrome – hope or hype? Crit Care. 2012;16(2):205.
  • Nie Y, Wang Z, Chai G, et al. Dehydrocostus lactone suppresses LPS-induced acute lung injury and macrophage activation through NF-κB signaling pathway mediated by p38 MAPK and Akt. Molecules. 2019;24(8):1510.
  • Li Y, Cao Y, Xiao J, et al. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Cell Death Differ. 2020;27(9):2635–2650.
  • Dong ZW, Yuan YF. Juglanin suppresses fibrosis and inflammation response caused by LPS in acute lung injury. Int J Mol Med. 2018;41(6):3353–3365.
  • Xiao K, He W, Guan W, et al. Mesenchymal stem cells reverse EMT process through blocking the activation of NF-κB and hedgehog pathways in LPS-induced acute lung injury. Cell Death Dis. 2020;11(10):863.
  • Liang Q, Cai W, Zhao Y, et al. Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis. Pharmacol Res. 2020;158:104884.
  • Wu YX, He HQ, Nie YJ, et al. Protostemonine effectively attenuates lipopolysaccharide-induced acute lung injury in mice. Acta Pharmacol Sin. 2018;39(1):85–96.
  • Nadeem A, Ahmad SF, Al-Harbi NO, et al. Inhibition of spleen tyrosine kinase signaling protects against acute lung injury through blockade of NADPH oxidase and IL-17A in neutrophils and γδ T cells respectively in mice. Int Immunopharmacol. 2019;68:39–47.
  • Ahmad SF, Zoheir KM, Ansari MA, et al. The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice. Mol Immunol. 2015;63(2):394–405.
  • Nadeem A, Siddiqui N, Al-Harbi NO, et al. Acute lung injury leads to depression-like symptoms through upregulation of neutrophilic and neuronal NADPH oxidase signaling in a murine model. Int Immunopharmacol. 2017;47:218–226.
  • Gouda MM, Bhandary YP. Acute lung injury: IL-17A-mediated inflammatory pathway and its regulation by curcumin. Inflammation. 2019;42(4):1160–1169.
  • Su ZQ, Mo ZZ, Liao JB, et al. Usnic acid protects LPS-induced acute lung injury in mice through attenuating inflammatory responses and oxidative stress. Int Immunopharmacol. 2014;22(2):371–378.
  • Konno K, Hirayama C, Yasui H, et al. Enzymatic activation of oleuropein: a protein crosslinker used as a chemical defense in the privet tree. Proc Natl Acad Sci USA. 1999;96(16):9159–9164.
  • Wang Y, Pan Y, Liu Y, et al. A new geniposidic acid derivative exerts antiaging effects through antioxidative stress and autophagy induction. Antioxidants. 2021;10(6):987.
  • Kaneko M, Iizuka T, Nakajima T. Inhibition effect of Eucommia ulmoides leaf extract on interleukin 8 production by A549 cells. Biol Pharm Bull. 2021;44(12):1891–1893.
  • Kim SJ, Kim KM, Park J, et al. Geniposidic acid protects against d-galactosamine and lipopolysaccharide-induced hepatic failure in mice. J Ethnopharmacol. 2013;146(1):271–277.
  • Chen H, Huang X, Min J, et al. Geniposidic acid protected against ANIT-induced hepatotoxicity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2. J Ethnopharmacol. 2016;179:197–207.
  • Baradaran Rahimi V, Rakhshandeh H, Raucci F, et al. Anti-inflammatory and anti-oxidant activity of Portulaca oleracea extract on LPS-induced rat lung injury. Molecules. 2019;24(1):139.
  • Luo X, Liu R, Zhang Z, et al. Mitochondrial division inhibitor 1 attenuates mitophagy in a rat model of acute lung injury. Biomed Res Int. 2019;2019:2193706.
  • Duan Y, Learoyd J, Meliton AY, et al. Inhibition of Pyk2 blocks lung inflammation and injury in a mouse model of acute lung injury. Respir Res. 2012;13(1):4.
  • Kong L, Deng J, Zhou X, et al. Sitagliptin activates the p62-Keap1-Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury. Cell Death Dis. 2021;12(10):928.
  • Gao Y, Chen ZY, Liang X, et al. Anti-atherosclerotic effect of geniposidic acid in a rabbit model and related cellular mechanisms. Pharm Biol. 2015;53(2):280–285.
  • Kröpfl JM, Schmid M, Di Marzio Y, et al. Circulating adult stem and progenitor cell numbers—can results be trusted? Stem Cell Res Ther. 2019;10(1):305.
  • Feiner JR, Weiskopf RB. Evaluating pulmonary function: an assessment of PaO2/FIO2. Crit Care Med. 2017;45(1):e40–e48.
  • Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury. Crit Care. 2019;23(1):44.
  • Zhang Z, Sun Y, Chen X. NLRC5 alleviated OGD/R-induced PC12-cell injury by inhibiting activation of the TLR4/MyD88/NF-κB pathway. J Int Med Res. 2020;48(8):300060520940455.
  • Mahendran S, Sethi T. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach? QJM. 2012;105(10):929–934.
  • Dempsey OJ, Miller D. Idiopathic pulmonary fibrosis. BMJ. 2013;347:f6579.
  • Ghaffari AR, Noshad H, Ostadi A, et al. Effect of pulse therapy with glucocorticoid and cyclophosphamide in lung fibrosis due to paraquat poisoning in rats. Saudi Med J. 2011;32(3):249–253.
  • Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care. 2001;7(1):1–7.
  • Al-Harbi NO, Imam F, Al-Harbi MM, et al. Dexamethasone attenuates LPS-induced acute lung injury through inhibition of NF-κB, COX-2, and pro-inflammatory mediators. Immunol Invest. 2016;45(4):349–369.
  • Nadeem A, Al-Harbi NO, Ahmad SF, et al. Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase-derived reactive oxygen species. Clin Exp Immunol. 2018;191(3):279–287.
  • Lu CN, Yuan ZG, Zhang XL, et al. Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway. Int Immunopharmacol. 2012;14(1):121–126.
  • Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab. 2000;85(9):3338–3342.
  • Nadeem A, Al-Harbi NO, Ahmad SF, et al. Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17/Treg immune responses and reduction of oxidative stress. Int Immunopharmacol. 2020;83:106369.
  • Cao C, Yin C, Shou S, et al. Ulinastatin protects against LPS-induced acute lung injury by attenuating TLR4/NF-κB pathway activation and reducing inflammatory mediators. Shock. 2018;50(5):595–605.
  • Tang QY, Wei JX, Xue SF, et al. Fibrogrowth factor-2 protects against acute lung injury by activating the PI3K/Akt signaling pathway. J Biol Regul Homeost Agents. 2020;34(5):1679–1688.
  • Deng G, He H, Chen Z, et al. Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway. Biomed Pharmacother. 2017;96:148–152.
  • Suzuki Y, Ruiz-Ortega M, Lorenzo O, et al. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35(6):881–900.
  • Sun H, Cai S, Zhang M, et al. MicroRNA-206 regulates vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Cell Biol Int. 2017;41(7):739–748.
  • Zhang T, Wang J, Wang S, et al. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway. Toxicol Mech Methods. 2015;25(9):665–671.
  • Johnson ER, Matthay MA. Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv. 2010;23(4):243–252.
  • Choi H, Shin B, Yoo H, et al. Early corticosteroid treatment for postoperative acute lung injury after lung cancer surgery. Ther Adv Respir Dis. 2019;13:1753466619840256.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.